SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis. - Zhao W; Wang X; Han L; Zhang C; Wang C; Kong D; Zhang M; Xu T; Li G; Hu G; Luo J; Yee SW; et al. (Nature communications, 2024)